# Righton

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/righton

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.rightongene.com
- Latest round: Series B (Feb 7, 2018)
- Investors on record: 4

## About

Based in Shanghai, China and established in 2014, Righton is a biotechnology company which focuses on biomedical technology, providing gene sequencing products. The company maintains a stable cooperative relationship with more than 150 tertiary A hospitals across the country.

The company’s main business is the research and development, production, sales and scientific research services of in vitro diagnostic products, mainly blood diseases (leukemia, lymphoma), solid tumors (lung cancer, colorectal cancer, melanoma, etc.) and infectious diseases (hepatitis B) , Rubella, herpes simplex, etc.) to provide accurate genetic and antigen detection for patients to provide a basis for the formulation of individualized treatment plans such as risk assessment, disease classification, targeted drug selection, and efficacy monitoring.

## Funding rounds

- Series B, Feb 7, 2018 — Cathay Capital
- Series B, Jun 20, 2017 — GTJA Investment Group, MingFeng Capital
- Angel, Jun 12, 2015 — JIC Capital

## Investors

- JIC Capital (https://capitalatlas.ai/funds/jic-capital) — Angel
- GTJA Investment Group (https://capitalatlas.ai/funds/gtja-investment-group) — Series B
- MingFeng Capital — Series B
- Cathay Capital — Series B